{"id":"W1566765736","doi":"10.25011/cim.v32i6.10662","title":"A Canadian multi-centre, open-label long-term study of Pegvisomant treatment in refractory acromegaly","year":2009,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; University of Alberta; Hôpital Notre-Dame; Pfizer (Canada); University of Toronto","funders":"Pfizer","keywords":"Pegvisomant; Acromegaly; Medicine; Refractory (planetary science); Internal medicine; Surgery; Endocrinology; Gastroenterology; Hormone; Growth hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001883579,0.001018088,0.001333985,0.0003417344,0.001668745,0.0006352778,0.0008400336,0.0009086317,0.002226067],"category_scores_gemma":[0.001438372,0.0003640675,0.0008470761,0.0009377947,0.001170861,0.0004368836,0.0003856445,0.001445105,0.00037618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007760933,"about_ca_system_score_gemma":0.01173128,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2923737,"about_ca_topic_score_gemma":0.4624642,"domain_scores_codex":[0.9990456,0.0003292534,0.00004433862,0.0001327216,0.0002516313,0.000196454],"domain_scores_gemma":[0.9979665,0.0001818442,0.0004275916,0.0001018479,0.000407728,0.0009145038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5546086,0.07533396,0.1411041,0.002522344,0.004853749,0.001332165,0.002217929,0.00361365,0.06325736,0.0004804616,0.01125912,0.1394166],"study_design_scores_gemma":[0.187276,0.2562987,0.5365891,0.000142786,0.00147045,0.0006274411,0.0004693436,0.001711936,0.002877936,0.0001295397,0.01222514,0.0001816752],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920244,0.002056547,0.0002409983,0.000338459,0.00004874714,0.00200805,0.001452685,0.0000228267,0.001807308],"genre_scores_gemma":[0.9929354,0.001048579,0.0009140681,0.0007908171,0.00009603842,0.0008351284,0.001664062,0.000009405005,0.001706457],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2923737,"threshold_uncertainty_score":0.5813439,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2308778405591441,"score_gpt":0.413914072213598,"score_spread":0.1830362316544539,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}